ZNF582 and neoplasm: Cumulatively, our results demonstrates for the first time that ZNF582-AS1 functions as a tumor suppressor gene in ccRCC, and ZNF582-AS1 may serve as a potential prognostic biomarker and therapeutic target of ccRCC.